Delivery Order SPE2DB20D9226-SPE2DB25FD1BJ
- Not listed
- On September 8, 2025, the Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Xtandi 40 mg capsules (120-count units). The contract, valued at $8,622.72, carries a firm fixed-price structure with an ultimate completion date of September 9, 2025. The delivery order carries no set-aside designation and represents performance at the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $8,622.72 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 40 mg capsules (120-count units). This firm fixed-price delivery order, issued on September 8, 2025, with an ultimate completion date of September 9, 2025, carries no set-aside designation. The award is issued under DMS Pharmaceutical Group's existing single-award Indefinite...
- On August 27, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $5,911.35 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 40 mg capsules (120-count units). This firm fixed-price delivery order, which has an ultimate completion date of August 28, 2025, was issued without a set-aside designation. The contract is being performed at the contractor's Park Ridge facility and...
- The Defense Logistics Agency awarded a $4.3K delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 40 mg capsules (120 count). The contract, issued as a firm fixed-price delivery order on September 9, 2025, with completion scheduled for September 10, 2025, represents a single pharmaceutical product delivery supporting Department of Defense healthcare operations. This award carries no...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,934.05 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 40 mg capsules (120-count units). The contract, effective August 12, 2025 with completion by August 13, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. This award represents a single transaction under DMS Pharmaceutical Group's larger...
- On August 11, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $8,622.72 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order covers 120 capsules of Xtandi 40 mg, an oncology treatment medication, under a firm fixed-price contract with an ultimate completion date of August 12, 2025. This award was issued without a set-aside designation, allowing DMS Pharmaceutical Group to compete...
- The Defense Logistics Agency awarded a delivery order valued at $12,934.05 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 40 mg capsules (quantity: 120). This firm fixed-price delivery order, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a continuation of the ongoing pharmaceutical supply relationship between the agency and the vendor. The award carries no...
- The Defense Logistics Agency awarded a delivery order valued at $4,311.35 to DMS Pharmaceutical Group Inc. on September 3, 2025, for the supply of Xtandi 40 mg capsules (120-count units). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this order for delivery to Park Ridge, IL. The contract utilizes a firm fixed-price structure with an ultimate completion date of September 4, 2025, and no set-aside designation...
- On July 28, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $4,169.59 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order, numbered 4568915549, covers the supply of Xtandi 40 mg tablets (120-count units), an oncology medication used in the treatment of prostate cancer. This firm fixed-price delivery order is scheduled for completion by July 29, 2025, with performance to take place...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,311.35 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 40 mg capsules (120-count). This firm fixed-price delivery order, issued on July 22, 2025, is expected to be completed by July 23, 2025, and carries no set-aside designation. The award falls under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the...
- SPE2DB20D9226Indefinite Delivery Contract
- SPE2DB20D9226-SPE2DB25FD1BJDelivery Order
On September 11, 2025, the Defense Logistics Agency awarded a delivery order valued at $8,622.72 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order, designated as Contract Number 4569422161, calls for the supply of Xtandi 40 mg capsules in a quantity of 120 units. This award represents a firm fixed-price delivery order with an ultimate completion date of September 12, 2025, and was issued without a set-aside designation. The place of performance is Park Ridge, Illinois. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency valued at approximately $500 million and valid through November 2026. Through this comprehensive contract vehicle, the company supplies a broad range of pharmaceutical products—including branded and generic prescription drugs, biologics, vaccines, and medical consumables—to support the medical supply needs of Department of Defense healthcare facilities nationwide. DMS Pharmaceutical Group's established role as a critical supplier in the federal pharmaceutical supply chain enables the Defense Logistics Agency to efficiently procure specialized medications such as Xtandi, an oncology treatment, for military health facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 9/11/25 |